Abstract
Hypomagnesemia is common after kidney transplantation. Until recently, only the determination of total plasma magnesium was possible, whereas the assessment of ionized magnesium has since become practicable. One hundred and nine renal transplant patients on cyclosporine with allografts functioning stably for more than 6 months and plasma creatinine levels of less than 200 μmol/l entered the study. Total and ionized circulating magnesium were assessed among these 109 patients, as well as among 15 renal transplant patients not on cyclosporine and 21 healthy volunteers. Cyclosporine patients showed significantly lower total and ionized circulating magnesium values than the two control groups. Plasma total and ionized magnesium levels were also significantly lower among cyclosporine patients treated concurrently with insulin or oral hypoglycemic agents than among those who were not. No correlation was noted between time after transplantation and plasma magnesium with respect to patients on cyclosporine. In conclusion, the study demonstrates that a large subset of renal transplant patients treated with cyclosporine have permanent deficiencies of ionized and total magnesium. The tendency towards hypomagnesemia is also more pronounced among patients with diabetes mellitus.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 28 May 1998 Received after revision: 27 November 1998 Accepted: 18 December 1998
About this article
Cite this article
Vannini, S., Mazzola, B., Rodoni, L. et al. Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine. Transpl Int 12, 244–249 (1999). https://doi.org/10.1007/s001470050217
Issue Date:
DOI: https://doi.org/10.1007/s001470050217